| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | LOXO ONCOLOGY INC COM | 4,028,920 | 105,477,000 | 21.73% | ||
| 2 | ZELTIQ AESTHETICS INCORPORATED | 1,609,727 | 63,133,000 | 13.01% | ||
| 3 | CYNAPSUS THERAPEUTICS INC | 1,121,381 | 45,102,000 | 9.29% | ||
| 4 | AIMMUNE THERAPEUTICS INC COM | 2,990,000 | 44,850,000 | 9.24% | ||
| 5 | VIEWRAY INC | 7,480,887 | 33,814,000 | 6.97% | ||
| 6 | VERSARTIS INC COM | 2,524,465 | 30,925,000 | 6.37% | ||
| 7 | CEMPRA INC | 1,193,060 | 28,872,000 | 5.95% | ||
| 8 | ADMA BIOLOGICS, INC. | 3,608,171 | 26,159,000 | 5.39% | ||
| 9 | Esperion Therapeutics Inc | 1,637,125 | 22,674,000 | 4.67% | ||
| 10 | T2 BIOSYSTEMS INC | 2,830,992 | 20,496,000 | 4.22% | ||
| 11 | Agile Therapeutics, Inc. | 2,275,455 | 15,883,000 | 3.27% | ||
| 12 | TRANSENTERIX INC | 8,335,819 | 14,088,000 | 2.90% | ||
| 13 | CIDARA THERAPEUTICS INC | 1,021,148 | 11,692,000 | 2.41% | ||
| 14 | SYROS PHARMACEUTICALS INC | 508,565 | 7,054,000 | 1.45% | ||
| 15 | PARATEK PHARMACEUTICALS INC | 482,680 | 6,280,000 | 1.29% | ||
| 16 | Intersect ENT Inc | 248,498 | 3,936,000 | 0.81% | ||
| 17 | CHIMERIX INC | 472,943 | 2,620,000 | 0.54% | ||
| 18 | PERNIX THERAPEUTICS HLDGS IN | 2,010,000 | 1,246,000 | 0.26% | ||
| 19 | PERNIX THERAPEUTICS HOLDINGS INC | 2,500,000 | 675,000 | 0.14% | PRN | |
| 20 | LOMBARD MEDICAL INC | 443,182 | 417,000 | 0.09% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950142-16-004693, filed 2016.11.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
